institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Weight Loss Drugs May Lower Risk of Dementia, Stroke: Study

TAIWAN, JUL 15 – A seven-year study of 60,000 people found GLP agonist drugs reduced dementia risk by 37% and stroke risk by 19% in individuals with type 2 diabetes and obesity.

  • A new study suggests that medications like Ozempic and Mounjaro may help protect against dementia and stroke.
  • During a seven-year follow-up, users of GLP agonist drugs had a 37% lower risk of dementia and a 19% reduced risk of stroke.
  • Researchers noted potential neuroprotective benefits of semaglutide and tirzepatide.
  • Type 2 diabetes patients taking semaglutide showed a significantly lower risk of dementia than those on other diabetic medications.
Insights by Ground AI
Does this summary seem wrong?

35 Articles

Craven HeraldCraven Herald
+14 Reposted by 14 other sources
Center

Weight loss jabs such as Mounjaro linked to lower dementia and stroke risk

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.

·Skipton, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 70% of the sources are Center
70% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Your Harlow broke the news in on Tuesday, July 15, 2025.
Sources are mostly out of (0)